Shock
what is shock
stages of shock
types of shock, their presentation and management
presentation is made for medical students using kumar and clark and guyton.
a clinical syndrome that results from inadequate tissue perfusion.
Hypovolemic shock - Blood or fluid loss, both leading to a decreased circulating blood volume, diastolic filling pressure, and volume.
Cardiogenic shock - due to cardiac pump failure related to loss of myocardial contractility/functional myocardium or structural/mechanical failure of the cardiac anatomy and characterized by elevations of diastolic filling pressures and volumes
Extra-cardiac/obstructive shock - due to obstruction to flow in the cardiovascular circuit and characterized by either impairment of diastolic filling or excessive afterload
Distributive shock - caused by loss of vasomotor control resulting in arteriolar/venular dilatation leading to a decrease in preload, with decreased, normal, or elevated cardiac output, depending on the presence of myocardial depression.
Septic shock, updated presentation, including latest guidelines from Intensive care societies and how to approach to the diagnosis with few notes about Early Goal Directed Therapy and role of steroids
د/باسم السيد
Management of shocked patient
المحاضرة التي قدمت يوم الثلاثاء 8 ابريل 2014 في دار الحكمة بالقاهرة
من فعاليات مشروع اعداد طبيب حكيم ناجح بالتعاون مع معتمد باتحاد الاطباء العرب
و ضمن موديول الطوارئ و التخدير و العناية المركزة
a clinical syndrome that results from inadequate tissue perfusion.
Hypovolemic shock - Blood or fluid loss, both leading to a decreased circulating blood volume, diastolic filling pressure, and volume.
Cardiogenic shock - due to cardiac pump failure related to loss of myocardial contractility/functional myocardium or structural/mechanical failure of the cardiac anatomy and characterized by elevations of diastolic filling pressures and volumes
Extra-cardiac/obstructive shock - due to obstruction to flow in the cardiovascular circuit and characterized by either impairment of diastolic filling or excessive afterload
Distributive shock - caused by loss of vasomotor control resulting in arteriolar/venular dilatation leading to a decrease in preload, with decreased, normal, or elevated cardiac output, depending on the presence of myocardial depression.
Septic shock, updated presentation, including latest guidelines from Intensive care societies and how to approach to the diagnosis with few notes about Early Goal Directed Therapy and role of steroids
د/باسم السيد
Management of shocked patient
المحاضرة التي قدمت يوم الثلاثاء 8 ابريل 2014 في دار الحكمة بالقاهرة
من فعاليات مشروع اعداد طبيب حكيم ناجح بالتعاون مع معتمد باتحاد الاطباء العرب
و ضمن موديول الطوارئ و التخدير و العناية المركزة
SHOCK SYNDROMESHOCK SYNDROME
• Shock is a condition in which the cardiovascular system
fails to perfuse tissues adequately
• An impaired cardiac pump, circulatory system, and/or
volume can lead to compromised blood flow to tissues
• Inadequate tissue perfusion can result in:
– generalized cellular hypoxia (starvation)
– widespread impairment of cellular metabolism
– tissue damage organ failure
– death
ATHOPHYSIOLOGYPATHOPHYSIOLOGY
Cells switch from aerobic to anaerobic metabolism
lactic acid production
Cell function ceases & swells
membrane becomes more permeable
electrolytes & fluids seep in & out of cell
Na+/K+ pump impaired
mitochondria damage
cell death
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. Acute circulatory failure with inadequate or
inappropriately distributed tissue perfusion
resulting in generalized cellular hypoxia and/or
an inability of the cells to utilize the oxygen.
3. CIRCULATORY
SHOCK
CIRCULATORY SHOCK
DUE TO DIMISHED
CARDIAC OUTPUT
CIRCULATORY SHOCK
CAUSED WITHOUT
DIMISHED CARDIAC
OUTPUT
(DISTRIBUTIVE SHOCK)
CARDIAC
ABNORMALITIES THAT
DIMISHED THE ABILITY
TO PUMP
FACTORS THAT
DECREASE THE
VENOUS RETURN
WHICH DECREASE THE
CARDIAC OUTPUT
RESTRICTED
CARDIAC FILLING
AND OBSTRUCTION
IN THE OUTFLOW
TRACT
CARDIOGENIC
SHOCK
HYPOVOLEMIC
SHOCK
OBSTRUCTIVE
SHOCK
SEPTIC SHOCK
ANAPHYLACTIC
SHOCK
NEUROGENIC
SHOCK
4. The end result of any type of shock would be-
• INADEQUATE O2
• INADEQUATE NUTRIENTS
• INADEQUATE REMOVAL OF WASTE PRODUCTS
5. STAGES OF SHOCK
I. NON PROGRESSIVE
Reversible stage where the compensatory mechanism get activated.
Person will fully recover without any external help.
II. PROGRESSIVE STAGE
Failing of compensatory mechanisms. Intervention is necessary to prevent
shock from further progression or progressing to irreversible stage.
III. IRREVERSIBLE OR REFRACTORY STAGE
DEATH IS IMMINENT!!!!
7. Osmoreceptors in hypothalamus stimulated
ADH (vasopressin) released by posterior pituitary
gland
Constrict peripheral vessels and increase water
retention
8. Anterior pituitary release ACTH
(adrenocorticotropic hormone)
Stimulate the adrenal cortex to release
glucocorticoids
Blood sugar levels increases to meet increase
metabolic needs
9. • Other mechanism that return the blood
volume back towards normal
Absorption of large quantities of fluid
from the intestinal tract
Absorption of fluid into blood capillaries
from interstitial space of the body
Increase thirst and appetite for salt.
10. PATHOPHYSIOLOGY OF SHOCK-PROGRESSIVE STAGE
Decrease cardiac output
Tissue hypo-perfusion
Cells switch from aerobic to anaerobic metabolism
lactic acid production
Cell function ceases & swells
membrane becomes more permeable
electrolytes & fluids seep in & out of cell
Na+/K+ pump impaired
mitochondria damage
Cell death
11.
12. • If low perfusion persists then shock will progress to
irreversible state where death is imminent.
• Even in irreversible shock, therapy can, on rare
occasions bring the arterial pressure and cardiac
output to near normal but circulatory system
nevertheless continues to deteriorate followed by
death within mins or hours
PATHOPHYSIOLOGY OF SHOCK-IRREVESIBLE STAGE
13. Clinical features of shock
Generalized shock
• mental status-
LOC
restless
Irritable
unresponsive
• Decreased urine output
Feature specific for each type of shock?
14. • Loss of circulating volume “EMPTY TANK”
‒ Loss of blood- trauma (blunt and penetrating)
BLOOD YOU SEE
BLOOD YOU DON’T SEE
‒ Loss of plasma- severe burns
‒ Loss of body sodium and consequent intravascular water
from diarrhea and vomiting
HYPOVOLEMIC SHOCK
16. 1. Hx of trauma, bleeding, burns, diarrhea and vomiting?
2. inadequate tissue perfusion
a) Skin- cold, pale, slate-grey, slow capillary filling time,
clammy
b) Kidney- oliguria, anuria
c) Brain-drowiness, confusion, irritability
2. Increased sympathetic tone-
a) Tachycardia, narrowed pulse pressure, weak or thready
pulse
b) Sweating
c) Blood pressure initially may be maintained later causes
hypotension
3. Metabolic acidosis- compensatory tachypnoea
17. S/S vary depending on severity of fluid loss:
• 15%[750ml]- compensatory mechanism maintains CO
• 15-30% [750-1500ml- Hypoxemia, hypotension, generalized
vasoconstriction and reduction in urine output to 20-30
ml/hour.
• 30-40% [1500-2000ml] -Impaired compensation & profound
shock along with severe acidosis
hypotension, tachycardia over 120, tachypnoea, urine output
under 20 ml/hour and the patient is confused.
• 40-50% - refractory stage:
marked hypotension, tachycardia and tachypnoea. No urine
output and the patient is comatose
loss of volume= death
18. • Put the patient on the bed.
• Have the person lie flat with the feet lifted about 12
inches to increase circulation. However, if the
person has a head, neck, back, or leg injury
• Nil by mouth
• Aim of Mx
Restoring circulatory volume
Tissue perfusion
Correct the cause
• Early recognition- don’t rely on BP (decreases only
when 30% of fluid is lost )
• Connect to a pulse oximeter – PR, RR, BP
• Give high flow oxygen
19. • Put two wide bore cannulas.
Blood for grouping, Rh and cross match blood
depending on loss.
Take blood for FBC, urea and electrolytes
Blood sugar
• ABG- acidosis
• Catheterize and UOP > 30ml/hr
• Trauma- no signs of external bleeding, look for
internal bleeding.
CT SCAN- Head injuries
USS- abdomen (blunt force trauma to abdomen)
• Transfuse blood if hemorrhage
• Electrolyte imbalance- correct it
20. • Burns- parkland formula
V (volume in ml) = 4 x body mass in kg (%surface area x 100)
Surface area by wallace rule of nine
• fluid replacement within 24 hours. The first half of this
amount is delivered within 8 hours from the burn incident,
and the remaining fluid is delivered in the next 16 hours.
21. • Resuscitate using crystalloids such as Normal saline,
hartmann solution.
• Insert a CVP line.
• If in pain iv anaglegics
• Control bleeding – surgery may be needed
22. • the impaired ability of the heart to pump
blood.
Causes
CARDIOGENIC SHOCK
Systolic
dysfunction
Diastolic
dysfunction
Increase after
load
Valvular
structural
abnormalities
Arrhythmias
MI Ventricular
hypertrophy
Aortic stenosis Papillary muscle
rupture
Ventricular
tachyarrhythmia
Myocardial
depressants-
antiarrythmics,
beta blockers,
calcium channel
blockers.
Restrictive
cardiomyopathy
Cardiac
tamponade
Malignant
hypertension
Aortic and mitral
regurgitation
23. Impaired pumping ability of left ventricle leads to
↓Stroke volume
↓Cardiac output
↓BP
↓Tissue perfusion
Inadequate systolic
emptying
↑Left ventricular filling
pressure (preload)
↑Left atrial pressure
↑Pulmonary artery and
capillary pressure
Pulmonary odeama
24. Symptoms may vary according to the cause.
• Signs of myocardial failure
a) Elevated JVP
b) gallop rhythm
c) basal coarse crackles
d) reduced pulse volume with tachycardia
e) low BP
• Obstructive – cardiac tamponade
a) Pulsus paradoxus
b) Muffled heart sound
• Symptoms and Signs of pulmonary emboli
a) Sudden onset dyspnoea
b) Tachypnoeic, tachycardia with hypotension
c) Localized Plural rub
d) Massive emboli- severe central chest pain
• Other signs
cold clammy peripheries with pallor and peripheral and central cyanosis
25. • Put the patient on to the bed.
• Best if the patient was in a coronary care unit.
• Give high flow oxygen via a face mask or if patient is
unconscious endotracheal tube.
• Connect the patient to a pulse oximeter and look for o2
saturation, BP, PR, RR
• Put two wide bore cannulas take blood for cardiac troponin,
FBC, blood gluocose, CRP, ESR, Urea and electrolytes, LFT.
• Meanwhile do a ECG and look for evidence of MI, arrythmias.
• Chest xray- cardiomegally and pulmonary odeama
26.
27. • Insert a urinary catheter to measure the UOP.
• Do a arterial blood gas analysis to identify metabolic
acidosis
28. • Ideally following parameter should be measure
a) Central venous pressure via a CVP Line
b) Mean arterial pressure via an arterial
pressure line
c) Pulmonary capillary wedge pressure
through a pulmonary artery catheter
29. a) central venous pressure via a CVP line
adequacy of patients circulating volume and
contractile state of the myocardium.
in cardiac failure venous pressure is usually high;
patient will not improve in response to volume
replacement which will cause further dramatic rise in
CVP.
30. b) mean arterial pressure through an arterial
pressure line
permits the rapid recognition of BP changes
Arterial cannulation also allows repeated arterial blood
gas samples to be drawn without injury to the patient.
Arterial lines can be placed in multiple arteries, including
the radial, ulnar, brachial, axillary, posterior tibial,
femoral, and dorsalis pedis arteries.
But the commonest site is radial artery and second
commonest is femoral artery
31. c)pulmonary capillary wedge pressure through a
pulmonary artery catheter
pressure measured by wedging a pulmonary catheter with an inflated
balloon into a small pulmonary arterial branch
Indirect measure of left atrial pressure
Gold standard in determining cause of acute pulmonary odeama.
diagnose severity of left ventricular failure and mitral stenosis
pulmonary edema with normal PWP suggested a diagnosis of acute
respiratory distress syndrome (ARDS) or non cardiogenic pulmonary
edema
32.
33. • Start an infusion of inotropic agents
Dobutamine infusion- if the patient is peripherally
vasoconstricted this is the drug of choice.
Start with 2.5 microgramas/kg/min
Maintain at 2.5-10 micrograms/kg/min
enable the SBP to be kept at 90mmhg.
34. • Dopamine infusion- if the patient is not
peripherally vasoconstricted
Start at 2.5 micrograms/kg/min
Main at 2.5-10 micrograms/kg/min
• If the PCWP is <15mmhg or if not measurable in
the background of hypovolemia and clear lung
field in CXR- give colloids/ plasma expanders
100ml every 15 mins untill PCWP is 15-20mmhg
• Excess fluid can be detrimental in cardiogenic
shock!
35. • Determine the cause of cardiogenic shock
Eg- MI, cardiac arrythmias, acute valvular dysfunction,
aortic aneurysms, cardiac tamponade
• Then treat according
MI- thrombolytics or Percutaneous intervention
Acute valvular dysfunction- surgery
Arrythmias- cardioversion
• Correct any metabolic and electrolyte imbalances
• SEEK SPECIALIST ADVICE EARLY.
36. • Systemic inflammatory response (SIRS) to infection
manifested by two or more of following.
• Temp > 38 or < 36 centigrade
• HR > 90
• RR > 20 or PaCO2 < 32
• WBC > 12,000/cu mm or < 4,000
• Septic shock is SIRS with confirmed infectious
process associated with hypotension and organ
failure.
SEPTIC SHOCK
37. • Initiated by gram negative (most commonly), gram
positive bacteria, fungi or viruses.
• Cell wall of organisms contain endotoxins or exotoxins
(antigenic protien produced by bacteria such as
staphylococcus, streptococcus and pseudomonas )
• Endotoxins causes release of inflammatory mediators
(systemic inflammatory response)
• Which causes vasodilatation and increased capillary
permeability
• Alters the peripheral circulation and massive dilation
leads to shock.
38.
39. • Clinical features
a) Fever and rigors
b) Nausea, vomiting
c) Vasodilation so warm peripheries
d) Bounding pulse
e) Rapid capillary refilling
f) Hypotension
g) evidence of infection at local site- lungs, kidneys,
meningies, brain, intra-abdominal.
Other signs
a) Jaundice
b) Come, stupor
c) Bleeding due to coagulopathy
d) rashes- and meningism
e) Hypoglycemia
40. • Put the patient on the bed.
• Hx and examination will be suggestive of septic shock
• Clear the airway and give high flow oxygen
If hypoxia persists intubation and ventilation may be necessary
• Put two wide bore cannulas and take blood for investigations
FBC, CRP
Blood glucose, urea and electrolytes, CT/BT
• Meanwhile catheterize the patient and send urine for UFR.
Maintain UOP > 30ml/hr
• Culture samples- blood, urine, CSF(meningitis), swabs from
open wounds
41. • Chest xray, uss abdomen, KUB
• 2D echo- if suspect endocarditis
• Maintain fluid balance with Normal saline or colloids
• Give fresh whole blood if Hb <10g/dL
• Fever- antipyretics – paracetamol 1 g 6hrly
• Hypotension managed by fluid replacement
If persistant give vasoconstrictor
Norepinephrine 1-12 micrograms/mins
And or
Epinephrine 1-12 micrograms/mins
42. • Use a combination of broad spectrum antibiotic. Select
appropriately according to the source of infection
• Get advice from a microbiologist
• Identify and drain any collection of pus/ septic foci. Seek
surgical assistance in ressecting dead tissues
• Treat the complications accordingly
Acute renal failure
Acute liver failure
DIC
Acute respiratory distress syndrome
• Once culture and ABST reports available treat accordingly
43. ANAPHYLACTIC SHOCK
• Results from widespread systemic allergic
reaction to an antigen
• LIFE THREATENING (Sometimes dead within
minutes)
44. Expoure to an antigen
Body stimulated produe IgE antibodies specific to the antigen
Rexposure to the antigen
IgE binds to mast cells and basophils
Which release histamine or a histamine like substance
Which causes
1. Increase in vascular capacity because of venous dilation causing
decrease venous return
2. Dilation of the arterioles, resulting in greatly reduced arterial
pressure
3. Greatly increased capillary permeability, with rapid loss of fluid
and protein into tissue space
45. • Also activated basophils and mast cells release mixture of
leukotrienes called slow reacting substance of anaphylaxis.
These causes spasms of the smooth muscles of bronchioles
• Antigens enter specific skin areas and cause localized
anaphylactoid reactions (urticaria). Histamine release
locally cause
―Vasodilation hence red flares
―Increase local permeability so swelling of skin
46. Present with chocking, coughing, stridor, wheezing,
breathless, LOC, itchy rash.
Hx of previous allergic reaction or anaphylactic
shocks?
1. Signs of profound vasodilation
a) Warm peripheries
b) Low BP
c) Tachycardia
2. Pale cyanosed
3. Erythema, urticaria,pluritus odeama of the face, pharynx and
larynx.
4. Bronchospasms, rhinitis
5. Nausea, vomiting, abdominal pain, diarrhea
47. Management
• Put the patient on the bed
• Establish airway patency and breathing
• If necessary endotracheal intubation, if it fails emergency
cricothyroidotomy
• Consult an anesthetist for advice regarding ventilation
• Give high flow oxygen
•
• Connect to a pulse oximeter and measure the
BP
Oxygen saturation
RR and PR.
• If Hypotensive- head low position
48. • Immediately give 0.5mg im adrenaline 1 : 1000 to vastus
lateralis
Repeat every 5 mins if shock persists
• Meanwhile put 2 large bore (14/16) cannulas
• Give iv chlorphenamine (antihistamine) 10-20mg or 25mg of
promethazine
• Give 100mg iv hydrocortisone
• If hypotension persists- 1-2L of normal saline
• Broncospams- nebulize with salbutamol 5mg
• Give oral steroids and antihistamine for 24-48 hrs or longer if
urticaria persists
49. Neurogenic shock
• Results from loss or suppression of sympathetic tone
which causes massive vasodilatation in the venous
vasculature therefore venous return decreases and
cardiac output decreases.
• Causes
Spinal cord injury above the level of T6
Deep general anesthesia (depress vasomotor centre)
Spinal anasthesia (block the sympathetic nervous
outflow)
Brain damage (contusions, concussions, ischemia)
50. Disruption of sympathetic nervous system
Loss of sympathetic tone
Venous and arterial vasodilatation
Decreased venous return
Decreased stroke volume
Decreased cardiac output
Decreased cellular oxygen supply
Impaired tissue perfusion
Impaired cellular metabolism
51. Present with paralysis below the level of lesion
On patient assessment
• Hypotension
• Bradycardia,
• Hypothermia
• Warm, dry skin
Goal of therapy is to treat or remove the cause and
prevent cardiovascular instability and promote
optimal tissue perfusion
52. • Put the patient on the bed
• Give high flow oxygen
• Examine the patient and find the level of lesion
• Connect to a pulse oximeter and measure RR, PR,
BP
• Put two wide bore cannulas.
• If hypovolemic- fluid replacement
• Observe closely for fluid overload- pulmonary
odeama
• Hypothermia- warming the patient
• CT/MRI of the spinal cord
53. • Alpha agonist to augment tone if perfusion still inadequate
dopamine (> 10 mcg/kg per min)
ephedrine (12.5-25 mg IV every 3-4 hour)
• Treat bradycardia with atropine 0.5-1 mg doses to
maximum 3 mg
• patient with obvious neurological deficit can be
given I.V. steroids, such as methylprednisolone in
high dose, within 8 hours of commencement of
neurogenic shock.
• Surgery is needed in case of accident/trauma/
injury/ to the patient.
54.
55. Case scenario
1. A 58 yr patient presented with central chest pain
of tightening nature radiating to the neck and left
arm. It was associated with sweating, nausea,
vomiting.
ECG showed a extensive anterior STEMI.
During the streptokinase infusion patients BP
dropped to 90/60mmhg.
What are the possible causes for hypotension?
How would you treat? And why?
56. It could be hypotension due to streptokinase allergy so
anaphylaxis shock or due to anterior MI causing
cargdiogenic shock or reperfusion arrythmia causing
cardiogenic shock
Treatment depends on type of shock
If its anaphylaxis due to streptokinase (confirm by looking
for other features like urticaria, swelling, warm
peripheries) streptokinase infusion should be stopped.
Ideally should give IM adrenaline 0.5ml 1:1000 units to
vastus lateralis.
However since this patient is just after a MI, adrenaline
may cause increase contractility of the heart, increase
excitation of the heart making it more prone for
arrythmias, increase the oxygen demand and
vasoconstriction may aggravate the tissue ischemia.
Therefore to correct this patient hypotension in
anaphylaxis shock would be to give a fluid bolus.
57. If the patient is having a cardiogenic shock due to the MI.
The MI involves the left ventricle hence reducing the
ability to contract. So we can administer dobutamine
which has a positive inotropic effect and which
decreases the afterload therefore improving the
cardiac output.
However if the case was an inferior STEMI it will involve
the right ventricle. So rather than giving dobutamine,
giving fluid boluses will increase the venous return to
right heart therefore venous return to left heart will
increase so LV which is functioning normally can pump
the blood to systemic circulation.